Mydecine Files Full Patent Application Covering New Formulations that Bring Nanoemulsion Technology to Traditional… Nov 3, 2021
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Part of Psychedelic Medicine Research Renaissance Nov 2, 2021
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin Oct 27, 2021
Mydecine Patent Filing Links Psychedelic Therapeutics & PTSD: Psychedelic Stock Investing Oct 7, 2021
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr.… Oct 5, 2021
